Protein Description

Gene Symbol MAPK7
Entrez ID 5598
Uniprot ID Q13164
Description mitogen-activated protein kinase 7
Chromosomal Location chr17: 19,377,721-19,383,544
Ontology GO ID GO Term Definition Evidence

BP

GO:0000165

MAPK cascade

An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.

IEA

BP

GO:0007049

cell cycle

The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.

IEA

BP

GO:0007165

signal transduction

The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

TAS

BP

GO:0018105

peptidyl-serine phosphorylation

The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.

IEA

BP

GO:0019933

cAMP-mediated signaling

Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.

NAS

BP

GO:0030154

cell differentiation

The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.

IEA

BP

GO:0030821

negative regulation of cAMP catabolic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).

NAS

BP

GO:0034115

negative regulation of heterotypic cell-cell adhesion

Any process that stops, prevents, or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion.

IGI

BP

GO:0036003

positive regulation of transcription from RNA polymerase II promoter in response to stress

Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).

IMP

BP

GO:0043407

negative regulation of MAP kinase activity

Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.

IEA

BP

GO:0045765

regulation of angiogenesis

Any process that modulates the frequency, rate or extent of angiogenesis.

IEA

BP

GO:0045944

positive regulation of transcription from RNA polymerase II promoter

Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.

IGI

BP

GO:0050728

negative regulation of inflammatory response

Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.

TAS

BP

GO:0051247

positive regulation of protein metabolic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein.

IGI

BP

GO:0051344

negative regulation of cyclic-nucleotide phosphodiesterase activity

Any process that stops or reduces the rate of cyclic nucleotide phosphodiesterase activity, the catalysis of the reaction: nucleotide 3',5'-cyclic phosphate + H2O = nucleotide 5'-phosphate.

NAS

BP

GO:0051534

negative regulation of NFAT protein import into nucleus

Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of an NFAT protein from the cytoplasm to the nucleus.

IEA

BP

GO:0060761

negative regulation of response to cytokine stimulus

Any process that decreases the rate, frequency, or extent of a response to cytokine stimulus.

IGI

BP

GO:0070301

cellular response to hydrogen peroxide

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.

IMP

BP

GO:0070377

negative regulation of ERK5 cascade

Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK5 cascade.

IEA

BP

GO:0071363

cellular response to growth factor stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.

IGI

BP

GO:0071499

cellular response to laminar fluid shear stress

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers.

IMP|TAS

BP

GO:0071560

cellular response to transforming growth factor beta stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.

IDA

BP

GO:1902176

negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway

Any process that stops, prevents or reduces the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway.

IMP

BP

GO:2000352

negative regulation of endothelial cell apoptotic process

Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.

IMP

BP

GO:2001240

negative regulation of extrinsic apoptotic signaling pathway in absence of ligand

Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.

IGI

CC

GO:0005634

nucleus

A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

IDA

CC

GO:0005654

nucleoplasm

That part of the nuclear content other than the chromosomes or the nucleolus.

IDA|TAS

CC

GO:0005737

cytoplasm

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

IDA

CC

GO:0005829

cytosol

The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

IDA|TAS

CC

GO:0016605

PML body

A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection.

IDA

MF

GO:0004674

protein serine/threonine kinase activity

Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.

TAS

MF

GO:0004707

MAP kinase activity

Catalysis of the reaction: protein + ATP = protein phosphate + ADP. This reaction is the phosphorylation of proteins. Mitogen-activated protein kinase; a family of protein kinases that perform a crucial step in relaying signals from the plasma membrane to the nucleus. They are activated by a wide range of proliferation- or differentiation-inducing signals; activation is strong with agonists such as polypeptide growth factors and tumor-promoting phorbol esters, but weak (in most cell backgrounds) by stress stimuli.

IEA

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0005524

ATP binding

Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.

IEA

MF

GO:0051019

mitogen-activated protein kinase binding

Interacting selectively and non-covalently with a mitogen-activated protein kinase.

IPI

Domain ID Description

IPR000719

Protein kinase domain

IPR003527

Mitogen-activated protein (MAP) kinase, conserved site

IPR008271

Serine/threonine-protein kinase, active site

IPR011009

Protein kinase-like domain

IPR011989

Armadillo-like helical

IPR017441

Protein kinase, ATP binding site

Pathway ID Pathway Term Pathway Source

hsa04010

MAPK signaling pathway

KEGG

hsa04540

Gap junction

KEGG

hsa04657

IL-17 signaling pathway

KEGG

hsa04722

Neurotrophin signaling pathway

KEGG

hsa04912

GnRH signaling pathway

KEGG

hsa04921

Oxytocin signaling pathway

KEGG

hsa05206

MicroRNAs in cancer

KEGG

hsa05418

Fluid shear stress and atherosclerosis

KEGG

WP437

EGF/EGFR Signaling Pathway

WikiPathways

WP3915

Angiopoietin Like Protein 8 Regulatory Pathway

WikiPathways

WP26

Signal Transduction of S1P Receptor

WikiPathways

WP306

Focal Adhesion

WikiPathways

WP481

Insulin Signaling

WikiPathways

WP3931

ESC Pluripotency Pathways

WikiPathways

WP185

Integrin-mediated Cell Adhesion

WikiPathways

WP382

MAPK Signaling Pathway

WikiPathways

WP1544

MicroRNAs in cardiomyocyte hypertrophy

WikiPathways

WP2795

Cardiac Hypertrophic Response

WikiPathways

WP2380

Brain-Derived Neurotrophic Factor (BDNF) signaling pathway

WikiPathways

h_hdacPathway

Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK)

BioCarta

h_mapkPathway

MAPKinase Signaling Pathway

BioCarta

h_erk5Pathway

Role of Erk5 in Neuronal Survival

BioCarta

UMLS CUI UMLS Term

C0020429

Hyperalgesia

No tissues found.

No databases found.

Pubmed ID Author Year Title

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

Gene Symbol Entrez ID Uniprot ID Score

PRKCD

5580

Q05655

0.00

RPS6KA1

6195

Q15418

0.00

RPS6KA3

6197

P51812

0.00

FOS

2353

P01100

0.52

MYC

4609

P01106

0.52

RXRA

6256

P19793

0.55

ACTB

60

P60709

0.63

ACTN4

81

O43707

0.63

ATP5A1

498

P25705

0.63

GOLGB1

2804

Q14789

0.63

HSPA4

3308

P34932

0.63

HSPA5

3309

P11021

0.63

LDHC

3948

P07864

0.63

PKM

5315

P14618

0.63

PPP3CA

5530

Q08209

0.63

FSCN1

6624

Q16658

0.63

TP53

7157

P04637

0.63

HSP90B1

7184

P14625

0.63

YWHAG

7532

P61981

0.63

YWHAH

7533

Q04917

0.63

YWHAZ

7534

P63104

0.63

NR1I2

8856

O75469

0.63

MAP3K2

10746

Q9Y2U5

0.63

UBE2C

11065

O00762

0.63

GANAB

23193

Q14697

0.63

FGF21

26291

Q9NSA1

0.63

GPSM3

63940

Q9Y4H4

0.63

MYLK2

85366

Q9H1R3

0.63

EGLN3

112399

Q9H6Z9

0.63

TUBB

203068

P07437

0.63

APP

351

P05067

0.66

NFE2L2

4780

Q16236

0.68

DSC1

1823

Q08554

0.72

DSG1

1828

Q02413

0.72

JUP

3728

P14923

0.72

PFDN1

5201

O60925

0.72

PFDN2

5202

Q9UHV9

0.72

PFDN4

5203

Q9NQP4

0.72

PFDN5

5204

Q99471

0.72

VBP1

7411

P61758

0.72

PFDN6

10471

O15212

0.72

HSP90AB1

3326

P08238

0.73

PRKCZ

5590

Q05513

0.73

CDC37

11140

Q16543

0.73

ETS1

2113

P14921

0.79

GAPDH

2597

P04406

0.82

YWHAE

7531

P62258

0.82

MAPK7

5598

Q13164

0.83

GJA1

2697

P17302

0.88

MEF2A

4205

Q02078

0.88

PML

5371

P29590

0.88

RAF1

5894

P04049

0.88

SGK1

6446

O00141

0.88

MEF2D

4209

Q14814

0.89

MAP2K5

5607

Q13163

0.89

YWHAB

7529

P31946

0.89

MEF2C

4208

Q06413

0.90

DUSP1

1843

P28562

0.00

DUSP3

1845

P51452

0.00

DUSP4

1846

Q13115

0.00

DUSP7

1849

Q16829

0.00

EGF

1950

P01133

0.00

MAPK3

5595

P27361

0.00

PRKCA

5578

P17252

0.49

ELK4

2005

P28324

0.55

HSP90AA1

3320

P07900

0.63

NTRK1

4914

P04629

0.63

XPO1

7514

O14980

0.63

SH2D2A

9047

Q9NP31

0.63

BAG3

9531

O95817

0.63

C5orf30

90355

Q96GV9

0.63

ZBED6CL

113763

Q96FA7

0.63

DOT1L

84444

Q8TEK3

0.72

PTPRR

5801

Q15256

0.79